BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fründt T, Krause L, Hussey E, Steinbach B, Köhler D, von Felden J, Schulze K, Lohse AW, Wege H, Schwarzenbach H. Diagnostic and Prognostic Value of miR-16, miR-146a, miR-192 and miR-221 in Exosomes of Hepatocellular Carcinoma and Liver Cirrhosis Patients. Cancers (Basel) 2021;13:2484. [PMID: 34069692 DOI: 10.3390/cancers13102484] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Hwang S, Yang YM. Exosomal microRNAs as diagnostic and therapeutic biomarkers in non-malignant liver diseases. Arch Pharm Res 2021;44:574-87. [PMID: 34165701 DOI: 10.1007/s12272-021-01338-2] [Reference Citation Analysis]
2 Zhou L, Shen M, Fan X, Liu Y, Yang L. Pathogenic and Potential Therapeutic Roles of Exosomes Derived From Immune Cells in Liver Diseases. Front Immunol 2022;13:810300. [DOI: 10.3389/fimmu.2022.810300] [Reference Citation Analysis]
3 Wang H, Zhang S, Li T, Wang L, Lv W, Wang S, Ma D, Zang Y, Zhu X, Xu Y, Zheng L, Shen J, Wei W. MicroRNA-146a promotes proliferation, migration, and invasion of HepG2 via regulating FLAP. Cancer Cell Int 2022;22:149. [PMID: 35410355 DOI: 10.1186/s12935-022-02568-0] [Reference Citation Analysis]